Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Medical Systems Reports Record Sales and Income for Fourth Quarter and Full Year.


Business Editors

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 12, 2004

Company Expects Continued Strong Growth in 2004

American American, river, 30 mi (48 km) long, rising in N central Calif. in the Sierra Nevada and flowing SW into the Sacramento River at Sacramento. The discovery of gold at Sutter's Mill (see Sutter, John Augustus) along the river in 1848 led to the California gold rush of  Medical Systems Holdings Inc. (Nasdaq:AMMD AMMD Aerodynamic Mass Median Diameter ) reported sales in the fourth quarter of 2003 of $47.2 million, a 24.6 percent increase over sales of $37.8 million in the comparable quarter of 2002 (21.3 percent before gain from foreign currency changes). Net income in the quarter was $10.3 million, or $0.30 per share, compared to $8.3 million, or $0.24 per share in the comparable quarter of 2002. Net income in 2002 benefited from a reduction in the Company's warranty An assurance, promise, or guaranty by one party that a particular statement of fact is true and may be relied upon by the other party.

Warranties are used in a variety of commercial situations. In many instances a business may voluntarily make a warranty.
 allowance which increased operating income Operating Income

The profit realized from a business' own operations.

Notes:
This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit.
 by $2.9 million and increased net income by $1.8 million or $0.05 per share. Net income in 2003 benefited from a further reduction in the Company's warranty allowance which increased operating income by $3.1 million and increased net income by $2.0 million or $0.06 per share. Without these warranty adjustments, net income for the quarter would have been $8.4 million, or $0.24 per share, compared to $6.5 million, or $0.19 per share in 2002. The reduction in the warranty allowance resulted from lower expected warranty claims. The changes in this allowance will be more fully discussed in the Company's annual report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 to be filed on or before March 19, 2004.

Net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 for the full year 2003 were $168.3 million, a 19 percent increase over sales of $141.6 million in 2002 (16 percent before foreign currency changes). Net income for the full year 2003 was $29.1 million, or $0.85 per share, compared to $24.9 million, or $0.73 per share, in 2002. Net income for the full years 2002 and 2003 benefited from the above-referenced warranty allowance reductions; full year 2002 also benefited from an after-tax af·ter-tax also af·ter·tax
adj.
Relating to or being that which remains after payment, especially of income taxes: after-tax profits. 
 gain of $0.4 million from reversing an accrued ac·crue  
v. ac·crued, ac·cru·ing, ac·crues

v.intr.
1. To come to one as a gain, addition, or increment: interest accruing in my savings account.

2.
 pension liability in connection with the 2002 pension fund termination The point where a line, channel or circuit ends. See SCSI termination and hybrid. . Without these adjustments, operating income for the full year 2003 would have been $38.5 million, and net income would have been $27.1 million, or $0.79 per share, compared to 2002 operating income of $35.2 million and net income of $22.6 million, or $0.66 per share. A summary of the effect of the warranty and pension adjustments for the fourth quarter and full year is attached.

Douglas Douglas, city, Isle of Man
Douglas, city (1991 pop. 19,950), capital of the Isle of Man, Great Britain. It is a popular resort, connected by rail to Ramsey and Port Erin, on the Irish Sea. Tourism is the chief industry.
 W. Kohrs, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , commented, "We are proud of our fourth-quarter and full year performance. Revenues from our major product groups continue to show growth, with women's health Women's Health Definition

Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
 revenue again leading the way and growing 80 percent for the quarter and 67 percent for the full year; erectile erectile /erec·tile/ (e-rek´til) capable of erection.

e·rec·tile
adj.
1. Of or relating to tissue capable of filling with blood and becoming rigid.

2.
 restoration revenues growing 7 percent in the quarter and 4 percent for the full year; and men's bladder bladder /blad·der/ (blad´er)
1. a membranous sac, such as one serving as receptacle for a secretion.

2. urinary bladder.
 control revenues growing 14 percent in the quarter and 13 percent for the full year. We are also pleased that the Company's tight control of operating expenses Operating expenses

The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted.
 allowed us to increase operating margins Operating Margin

A ratio used to measure a company's pricing strategy and operating efficiency.

Calculated by:
 above 25 percent in the fourth quarter."

The Company also announced it had completed its previously announced move of the CryoGen cry·o·gen
n.
A liquid, such as liquid nitrogen, that boils at a temperature below about 110 Kelvin (-160°C) and is used to obtain very low temperatures; a refrigerant.
 operations into its Minnesota Minnesota, state, United States
Minnesota (mĭn'ĭsō`tə), upper midwestern state of the United States. It is bordered by Lake Superior and Wisconsin (E), Iowa (S), South Dakota and North Dakota (W), and the Canadian provinces
 facility, at a one-time one-time
adj.
1. or one·time
a. Occurring or undertaken only once: a one-time winner in 1995.

b.
 cost in the quarter of $0.7 million dollars, and it is no longer reporting operating or net losses for CryoGen separately.

Outlook

Looking forward, Mr. Kohrs said the Company expects 2004 full year sales to increase 16 to 19 percent over 2003 sales, with growth in all major product groups, and earnings per share of $0.94 to $0.98. In the first quarter of 2004, the Company expects total revenues to be in the range of $46 to $48 million dollars, and earnings per share of $0.22 to $0.24.

Earnings Call Information

American Medical Systems will host a conference call today at 5:00 p.m. eastern time to discuss its fourth quarter and fiscal year 2003 results. A live web cast of the call is available through the Company's corporate website at www.AmericanMedicalSystems.com; the replay will be available beginning two hours after completion of the call.

About American Medical Systems

American Medical Systems, headquartered in Minnetonka, Minnesota For other uses, see Minnetonka (disambiguation).
Minnetonka is a suburban community located eight miles west of Minneapolis in Hennepin County. Its 2000 population of 51,480 makes it the fourteenth largest city in Minnesota.
, is a world leader in medical devices and procedures to treat incontinence incontinence

Inability to control excretion. Starting and stopping urination relies on normal function in pelvic and abdominal muscles, diaphragm, and control nerves. Babies' nervous systems are too immature for urinary control. Later incontinence may reflect disorders (e.g.
, erectile dysfunction Erectile Dysfunction Definition

Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse.
 (ED), urinary urinary /uri·nary/ (u´ri-nar?e) pertaining to, containing, or secreting urine.

u·ri·nar·y
adj.
1. Relating to urine and its production, function, or excretion.

2.
 obstructions (caused primarily by enlarged prostate Enlarged Prostate Definition

A non-cancerous condition that affects many men past 50 years of age, enlarged prostate makes urinating more difficult by narrowing the urethra, a tube running from the bladder through the prostate gland.
 or surgery to treat prostate prostate /pros·tate/ (pros´tat) a gland surrounding the bladder neck and urethra in the male; it contributes a secretion to the semen.prostat´ic

pros·tate
n.
The prostate gland.

adj.
 disease), menorrhagia menorrhagia /men·or·rha·gia/ (men?ah-ra´jah) hypermenorrhea.

men·or·rha·gia
n.
See hypermenorrhea.
, and other pelvic floor The pelvic floor or pelvic diaphragm is composed of muscle fibers of the levator ani, the coccygeus, and associated connective tissue which span the area underneath the pelvis.  defects. Although not life-threatening Adj. 1. life-threatening - causing fear or anxiety by threatening great harm; "a dangerous operation"; "a grave situation"; "a grave illness"; "grievous bodily harm"; "a serious wound"; "a serious turn of events"; "a severe case of pneumonia"; "a life-threatening , these disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the Years, The

the seven decades of Eleanor Pargiter’s life. [Br. Lit.: Benét, 1109]

See : Time
 number of people seeking treatment has increased markedly as a result of longer life expectancy Life Expectancy

1. The age until which a person is expected to live.

2. The remaining number of years an individual is expected to live, based on IRS issued life expectancy tables.
, higher quality-of-life expectations, and greater awareness of new treatment alternatives. American Medical Systems' products reduce or eliminate the incapacitating in·ca·pac·i·tate  
tr.v. in·ca·pac·i·tat·ed, in·ca·pac·i·tat·ing, in·ca·pac·i·tates
1. To deprive of strength or ability; disable.

2. To make legally ineligible; disqualify.
 effects of these diseases, often through minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. . The company believes its products were used to treat over 100,000 patients in 54 countries during the last 12 months. More information about the company and its products may be found at: www.AmericanMedicalSystems.com.

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.


Statements about the Company's future sales, warranty claims, and financial results are forward-looking statements subject to risks and uncertainties including the timing and success of new product introductions, continued physician endorsement A signature on a Commercial Paper or document.

An endorsement on a negotiable instrument, such as a check or a promissory note, has the effect of transferring all the rights represented by the instrument to another individual.
 and use of the company's products, competitor activities, changes in reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 rates, and potential product recalls. These risks and uncertainties are more fully described in the company's Annual Report on Form 10-K for the year ended December December: see month.  28, 2002, and its other, more recent, filings. Actual results may differ materially from anticipated results.


Statements Of Operations
(In thousands, except per share data)

                                   Three months       Twelve months
                                 through December   through December
                                 ----------------- -------------------
                                   2002     2003     2002      2003
                                 -------- -------- --------- ---------

Net sales                        $37,832  $47,153  $141,648  $168,283

Operating expenses
  Cost of sales
    Recurring                       7033    9,034    27,518    30,468
    Change in warranty allowance  (2,913)  (3,115)   (2,913)   (3,115)
                                 -------- -------- --------- ---------
    Total cost of sales            4,120    5,919    24,605    27,353
  Marketing and sales             12,957   16,298    50,152    63,324
  Research and development         3,131    3,911    11,858    14,924
  General and administrative       3,372    4,857    13,186    16,882
  Amortization of intangibles        958      906     3,775     4,160
                                 -------- -------- --------- ---------
  Total operating expenses        24,538   31,891   103,576   126,643

Operating income                  13,294   15,262    38,072    41,640

Other income (expense)
  Royalty income                     750      622     3,032     2,797
  Other income                       181      570     1,140     1,004
  Interest expense, net             (776)     (42)   (1,628)   (1,352)
                                 -------- -------- --------- ---------
  Total other income                 155    1,150     2,544     2,449

Income before income taxes        13,449   16,412    40,616    44,089

Provision for income taxes         5,118    6,093    15,730    15,039
                                 -------- -------- --------- ---------

Net income                        $8,331  $10,319   $24,886   $29,050
                                 ======== ======== ========= =========

Net income per share
  Basic                            $0.26    $0.31     $0.77     $0.88
  Diluted                          $0.24    $0.30     $0.73     $0.85

Weighted average shares
  Basic                           32,466   33,079    32,232    32,854
  Diluted                         34,054   34,626    34,176    34,313




Consolidated Balance Sheets
(In thousands)


                                             December 28,  January 3,
                                                 2002          2004
                                             ------------  -----------


Assets
 Current assets
   Cash and short-term investments               $79,429      $58,953
   Accounts receivable, net                       27,208       33,458
   Inventories                                    13,475       18,402
   Deferred taxes and other current assets         5,697        8,533
                                             ------------  -----------
   Total current assets                          125,809      119,346

 Property, plant and equipment, net               21,328       25,489
 Goodwill and intangibles, net                    96,298      118,279
 Deferred taxes and other assets                   8,210       16,264
                                             ------------  -----------
 Total assets                                   $251,645     $279,378
                                             ============  ===========

Liabilities and stockholders' equity
 Current liabilities
   Accounts payable                               $3,000       $4,621
   Accrued liabilities and taxes                  19,523       18,097
   Current portion of notes payable                6,000        7,159
                                             ------------  -----------
   Total current liabilities                      28,523       29,877

 Long-term notes payable                          18,000        9,205
 Other long-term liability                           860            0

 Stockholder's equity                            204,262      240,296
                                             ------------  -----------

 Total liabilities and stockholders' equity     $251,645     $279,378
                                             ============  ===========




Condensed Statements Of Cash Flows
(In thousands)

                                               Twelve months through
                                              ------------------------
                                              December 28, January 3,
                                                  2002         2004
                                              ------------ -----------

Cash flows from operating activities
 Net income                                       $24,886     $29,050
 Adjustments to reconcile net income to
    net cash provided by operating activities:
  Depreciation                                      3,971       5,382
  Amortization of intangibles, including
   deferred financing costs                         4,195       4,391
  Noncash deferred compensation                       176         135
  Income tax benefit related to stock option
   plans                                            1,043       1,670
  Noncash stock-based compensation                     46          35
  Change in net deferred taxes                      3,652       3,761
  Changes in operating assets and liabilities      (9,131)    (11,261)
                                              ------------ -----------
  Net cash provided by operating activities        28,838      33,163

Cash flows from investing activities
 Purchase of property, plant and equipment         (1,695)     (5,121)
 Purchase of businesses, net of cash acquired           0     (43,803)
 Purchase of investments in technology             (1,000)          0
 Purchase of other intangibles                     (1,010)          0
 Sales of investments, net of purchases            27,796           0
                                              ------------ -----------
 Net cash provided by (used in) investing
  activities                                       24,091     (48,924)

Cash flows from financing activities
 Issuance of common stock                           2,351       2,639
 Payments on long-term debt                        (4,909)     (8,228)
                                              ------------ -----------
 Net cash used in financing activities             (2,558)     (5,589)

Effect of exchange rates                              303         874
                                              ------------ -----------

Net increase (decrease) in cash and cash
 equivalents                                      $50,674    ($20,476)
                                              ============ ===========




Selected Sales Information
(In thousands)


                                   Three months       Twelve months
                                 through December   through December
                                 ----------------- -------------------
                                   2002     2003     2002      2003
                                 -------- -------- --------- ---------

Sales
 Product line
  Men's health
     Erectile restoration        $18,264  $19,509   $69,554   $72,385
     Bladder control               9,366   10,694    35,316    39,758
     Prostate treatment            1,482    1,224     6,063     4,923
                                 -------- -------- --------- ---------
     Total                        29,112   31,427   110,933   117,066

  Women's health                   8,720   15,726    30,715    51,217
                                 -------- -------- --------- ---------

  Total                          $37,832  $47,153  $141,648  $168,283
                                 ======== ======== ========= =========

 Geography
  United States                  $30,320  $37,476  $116,523  $136,765

  Outside United States
    Before currency                7,512    8,405    25,125    27,593
    Currency impact                    0    1,272         0     3,925
                                 -------- -------- --------- ---------
    Total                          7,512    9,677    25,125    31,518
                                 -------- -------- --------- ---------

  Total                          $37,832  $47,153  $141,648  $168,283
                                 ======== ======== ========= =========




Adjustments to Operating Income, Net Income,
And Earnings Per Share for Consistent
Presentation from 2002 to 2003
(In thousands, except per share data)



                                     Three months      Twelve months
                                   through December  through December
                                   ----------------- -----------------
                                     2002     2003     2002     2003
                                   -------- -------- -------- --------

Adjustments in operating income

 Reported operating income         $13,294  $15,262  $38,072  $41,640

 Adjust for change in warranty
  allowance                         (2,913)  (3,115)  (2,913)  (3,115)
                                   -------- -------- -------- --------

 Adjusted operating income         $10,381  $12,147  $35,159  $38,525
                                   ======== ======== ======== ========


Adjustments in net income

 Reported net income                 8,331   10,319   24,886   29,050

 Decrease in net income
  Change in warranty allowance
   Decrease in operating income     (2,913)  (3,115)  (2,913)  (3,115)
   Tax impact                        1,109    1,162    1,109    1,162
                                   -------- -------- -------- --------
   Decrease in net income           (1,804)  (1,953)  (1,804)  (1,953)

  Adjust for 2002 pension fund
   termination
   Pension accrual reversal              0        0     (716)       0
   Tax impact                            0        0      272        0
                                   -------- -------- -------- --------
   Decrease in net income                0        0     (444)       0
                                   -------- -------- -------- --------

  Total decrease in net income      (1,804)  (1,953)  (2,248)  (1,953)
                                   -------- -------- -------- --------

 Adjusted net income                $6,527   $8,366  $22,638  $27,097
                                   ======== ======== ======== ========

Net income per share
 Reported
  Basic                              $0.26    $0.31    $0.77    $0.88
  Diluted                            $0.24    $0.30    $0.73    $0.85

 Adjusted
  Basic                              $0.20    $0.25    $0.70    $0.82
  Diluted                            $0.19    $0.24    $0.66    $0.79
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 12, 2004
Words:1878
Previous Article:Hythiam, Inc. to Present at Roth Capital Partners' 16th Annual Growth Stock Conference.
Next Article:Tegal Corporation Reports Third Quarter Fiscal 2004 Financial Results; New $25 million structured secondary offering facility to fund expansion in...
Topics:



Related Articles
Interpore Cross Achieves Record Sales and Earnings for Fourth Quarter and Year Ended Dec. 31, 1999; Company Posts More Than 30% Revenue Growth for...
Guidant Reports Fourth Quarter Sales Increase of 13 Percent to $649 Million; Record Fourth Quarter Earnings, as Adjusted, of $0.41 per Share.
American Medical Systems Reports Record Sales and Income Growth for Fourth Quarter and Full Year.
Henry Schein Achieves Record Financial Performance; Company Reports Q4 Sales of $698 Million, EPS of $0.62, Operating Cash Flow of $112 Million.
St. Jude Medical Reports Record 2002 Results Led by Strong ICD and Angio-Seal Sales.
American Medical Systems Reports Record Sales and Income for Fourth Quarter and Full Year.
VIASYS Healthcare Inc. Reports Fourth Quarter and Full Year Earnings.
Mentor Reports Record Results and Provides Guidance for Fiscal Year 2006.
St. Jude Medical Reports Fourth Quarter and Full-Year 2006 Results.
American Medical Systems' Total Revenue Increases 58 Percent to $115.4 Million; Core Revenue Increases 18 Percent.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles